1.gif (1892 bytes)                      

Correspondence

Indian Pediatrics 2007; 44:3468-469

Tips to Treat Asthma


I read with interest the article titled "Adherence issues in Asthma" published in the December issue of Indian Pediatrics and would like to share our experiences over the past one and half decade at our Asthma clinic at Bangalore.

1. The successful adherence to inhaled medications by the parents and the child will mainly depend upon the time spent by the physician during the first visit to explain, convince and support them.

2. The concept of Blue (reliever) and Brown (controller) and their differing yet contributory effects on Asthma control needs to be explained clearly during the first visit itself. Otherwise, as the Blue inhalers are less expensive and the Brown inhalers relatively 4 times the cost, and the effect of the Blue inhalations being evident within fifteen minutes in contrast to the brown inhalers which take weeks to perceive their effects, most often the Blue inhalers replace the Brown ones very shortly after initiation.

3. At each followup visit, the physician should always check, reinforce the technique of inhalation as well as encourage the child if he is compliant. Parents should carry the inhalers and the spacers and facemasks with them during followup visits. Serial peakflow recordings help in this regard.

4. Spacers should be an integral part of inhalation therapy along with metered dose inhalers . Face masks should be used when appropriate.

5. The success story of a child and his family with proper inhalation therapy should be shared with other parents during parent education sessions so as to motivate them to continue enthusiastically.

6. The time of consultation for children with asthma should be separate from the usual consultation hours in order to provide sufficient time to the child and his family.

7. Defaulting parents are receptive when they bring their child with acute exacerbations. This situation should be utilized optimally to bring home the concept that regular controller medications do prevent /bring down acute exacerbations.

8. To write the date of purchase on the inhaler will be useful to assess compliance to some extent.

Last but not least, a knowledgable and compassionate physician who spends time and understands the child and his family dynamics and not merely the disease process is the key to successful adherence.

S. Nagabhushana,
Professor of Pediatrics,
M.V.J. Medical College,
Hoskote, Bangalore, India.
E-mail: [email protected]

REFERENCES

1. Bagga A. Steroid resistant nephrotic syndrome recent developments. Indian Pediatr 2006; 43: 9-13.

2. Gulati S, Sengupta D, Sharma RK, Sharma AP, U Singh, Gupta RK et. al. Steroid resistant nephrotic syndrome -role of histopathology. Indian Pediatr 2006. 43 ; 55-60.

3. Gulati S, Kher V. Intravenous pulse cyclophosphamide - a new regime for steroid resistant focal segmental glomerulosclerosis. Indian Pediatrics 2000; 37: 141-148.

4. Habashy D, Hodson EM, Craig JC. Interventions for steroid-resistant nephrotic syndrome: a systematic review. Pediatr Nephrol 2003; 18: 906-912.

5. Nammalwar BR, Vijaykumar M, Prahlad N, Jain DV. Steroid resistant nephrotic syndrome: Is sustained remission attainable? Indian Pediatr 2006; 43: 39-43.

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription